Track 1: Genetics and Molecular Biology in Gastroenterology

Molecular biology has become an integral part of basic gastroenterology and clinical gastroenterology. A broad spectrum of infectious, inherited and malignant gastrointestinal diseases can now be studied by molecular methods, including polymerase chain reaction, hybridization and DNA sequence analysis. Recent progress in the molecular analysis of   Colorectal cancer and Whipple's disease  two major problem in Clinical gastroenterology.

Genetics have led to an increased understanding of the genetic determinants of GI disorders. Currently recognized clinical indications for genetic testing covers diagnostic testing, presymptomatic testing, new-born screening, carrier testing, pharamacogenetic testing, prenatal testing.

Track 2: Gastrointestinal Immunology

Gastrointestinal Immunology mainly focus on differentiation of gut-associated lymphoid tissue, regulation of innate and adaptive immune cell differentiation and function, genetic and epigenetic factors regulating immune responses and inflammation. It also gives idea about the clinical research, clinical trials and epidemiology studies on gastrointestinal inflammatory diseases including but not limited to gluten-sensitive enteropathy, inflammatory bowel disease, and gastritis, malabsorption syndromes, diarrhea, gastric and duodenal ulcers and disease of the salivary glands excluding cystic fibrosis.

Track 3: Pediatric / Neonatal Gastroenterology and Nutrition

Pediatric Gastroenterology is subjected with treating the GIT , liver and pancreas of children from infancy till adulthood. Testing is done using PH Probes, Liver Biopsies, Breath Test, Endoscopic Procedure.

The main aim of the study of pediatric gastroenterology is to scale down infant and child rate of deaths, control the spread of infectious disease, and promote healthy lifestyles for a long disease-free life aid ease the issue of children and adolescents.

Track 4: Gastrointestinal Pathology

Gastrointestinal Pathology is sub discipline of surgical Pathology. It deals with the analysis and exposure of neoplastic and non-neoplastic diseases of the digestive tract and accessory organs, such as the pancreas and liver.

Pathology diagnosis is a critical determinant of future screening interval and cancer risk, many of these diagnoses do not result in significant mortality for patients; thus, errors may be "masked" by the limited effect to the patient in the present context.

Track 5: Gastrointestinal Oncology

Digestive cancers can have wide-ranging effects on nutritional status, health, and quality of life. It shows the symptoms of internal bleeding, acute pains, swelling, inability to digest, difficulty in swallowing or chronic constipation or acute diarrhea.

The diagnosis often requires endoscopy, pursued by biopsy of  doubtful tissue. The treatment depends upon the tumour location, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere, these factors also determine the prognosis. Esophageal cancer is the 6^th common cancer in the world, and its number is increasing.

Track 6: Gastrointestinal Radiology

Radiology can be done in many ways like x-ray, computed tomography, Magnetic resonance imaging. Computed tomography  allows comprehensive assessment of abdominal, pelvic inflammatory, infectious processes, obstruction, tumour detection, display of vasculature, staging and blunt trauma effects.

Barium studies of the gastrointestinal tract, enteroclysis for conventional radiography  and small-bowel assessment still have a role, despite the extensive use of fiberoptic endoscopy. Fluoroscopy is important, but great advances in technologies have changed gastrointestinal radiology irrevocably.

Track 7: Gastrointestinal Disorders

Gastrointestinal motility can be described by the movements of the digestive system, and the transit of the contents within it. Gastrointestinal Disorder is   related to gastrointestinal tract namely the esophagus, stomach, small intestine, large intestine, rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Gastrointestinal disorders include such conditions as constipation, hemorrhoids, irritable bowel syndrome, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases,  colon polyps, colitis and cancer. Many of these can be  minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.

Gastrointestinal disorders research remains severely underfunded. Less than 1% of digestive disease research funding, through the National Institutes of Health (NIH), is allocated for functional disorders.

Track 8: Digestive Disorders

Common digestive problems include heartburn/GERD, IBD, and IBS. Symptoms may include bloating, gas, stomach pain, diarrhoea, and stomach cramps. Treatment includes a combination of medication and lifestyle changes. Treatment includes drugs that reduce acid levels, such as the proton pump inhibitors Aciphex, Nexium, Prevacid, Prilosec, and Protonix and the H2 blockers Axid, Pepcid, Tagamet, and Zantac

The above mentioned all Digestive disorder, Achalasia is dangerous as it  a failure of smooth muscle fibers to relax, which can cause a sphincter to remain closed and fail to open when needed.  The main symptoms of achalasia are chest pain behind the sternum, regurgitation of undigested food, dysphagia (difficulty in swallowing) and weight loss.

Track 9: Pancreatic Diseases

Pancreas will produces juices which  helps to break down food and hormones that  control blood sugar levels. Problems with the pancreas can lead to many health problems like pancreatitis, exocrine pancreatic insufficiency and pancreatic cancer.

The pancreas additionally assumes a part in diabetes. In type 1 diabetes, the beta cells of the pancreas never again make insulin in light of the fact that the body's resistant framework has assaulted them. In type2 diabetes, the pancreas loses the capacity to emit enough insulin.

Track 10: Inflammatory Bowel Disease: Types, Causes, and Risk Factors

Inflammatory bowel disease (IBD) is a band of inflammatory conditions of the colon and small intestine. Crohn's disease and ulcerative colitis are the most important types of inflammatory bowel disease. It not only affects the small and large intestine but also affects the mouth, oesophagus, stomach and the anus.

The following symptoms are abdominal pain, vomiting, diarrhea, rectal bleeding, and severe internal cramps/muscle spasms in the region of the pelvis and weight loss. Diagnosis is generally done by assessment of inflammatory markers in stool followed by colonoscopy with biopsy of pathological lesions.

Track 11: Colorectal Disease: Treatments & Diagnosis

Colorectal Diseases (CRD) varies from benign lesions to malignant and cancerous masses. Several tests and procedures to screen and diagnose colorectal disease, including one or more of the following  Colonoscopy, flexible sigmoidoscopy, Endoscopic ultrasound, Capsule endoscopy.

 Various medical and surgical treatment options for colorectal disease, including: Endoscopic mucosal resection, faecal microbiota transplant, Bowel resection, J-pouch surgery.

Track 12: Liver Diseases & Hepatitis

Liver sickness (likewise called hepatic infection) is a sort of harm to or ailment of the liver. There are hundred various types of liver disease, symptoms may incorporate jaundice and weight loss.er ailment can happen through a few components. Viral hepatitis like Hepatitis B infection and Hepatitis C infection) can be vertically transmitted amid birth by means of contact with contaminated blood.

A number of liver function tests (LFTs) are now available to test the proper function of the liver. Anti-viral medications are available to treat infections such as hepatitis B. Other conditions may be managed by slowing down disease progression.

Track 13: Gastroenterology: Clinical and Diagnostics

The gastrointestinal diseases need pharmacological treatment for cure, are they are divided into 2 categories- the prescription drugs and Over the Counter (OTC) drugs. GI drugs are prescribed based on the diagnostic results yielded during the haematological or imaging tests. The most common diagnosis is done through endoscopy. The therapies will be based on gastrointestinal tract disorders, gastrointestinal motility disorders, gastrointestinal cancers.

Probiotics are not regulated and only few randomized controlled trials exist investigating their efficacy in different GI disorders

Peritoneal infections are classified as primary, secondary, or tertiary. Antibiotic are used to prevent local and haematogenous spread of an intra-abdominal infection and to reduce late complications. Several  antibiotic regimens are available for the treatment of intra-abdominal infections.

Track 14: Gastrointestinal Surgery

Gastrointestinal surgery is divided into upper GI surgery and lower GI surgery. Upper GI Surgery includes surgery for gastro-oesophageal reflux, Gall bladder disease, Hernias, other benign oesophageal and gastric disorders, other benign pancreatic and hepatobiliary disorders. Lower gastrointestinal surgery includes colorectal surgery and surgery of the small intestine.

Laparoscope is a fiber-optic gadget that transmits pictures from internal part of the body to a video screen when embedded in the stomach divider.

Track 15: Hepato-pancreatic-biliary(HPB) and Transplant Surgery

HPB stands for Hepato-Pancreatic-Biliary Surgery - meaning surgery of the liver, pancreas and biliary system. HPB surgeons help to diagnose and treat patients with conditions such as liver cancer (primary or secondary), pancreatic cancer, pancreatitis, bile duct cancer and gallstones. 

HPB surgery requires technical expertise in challenging operations that have significant risk of major complications. Further, an association between volume of operations performed (both by the individual and hospital) and surgical outcome has been well established in relation to operations such as major hepatic and pancreatic resections.

Track 16: Minimally Invasive surgery

Minimally invasive surgery uses tiny cuts or no cuts on the skin rather than the large cuts which are often needed in traditional surgery.

There are many kinds of minimally invasive surgery. Each involves the surgeon using an endoscope.  There is a thin tube with a light and tiny video camera at the end. The endoscope will let the surgeon to see inside the body and use very small surgical tools in the area.

Track 17: Obesity or Bariatric Surgery

Obesity has become the global health problem that contributes to numerous life-threatening and disabling diseases, such as type 2 diabetes mellitus and coronary artery disease.

Bariatric surgery (weight loss surgery)is the technique used to treat the obese person. The U.S. National Institutes of Health prescribes bariatric surgery for corpulent individuals with a body mass record (BMI) of no less than 40, and for individuals with BMI of no less than 35 and genuine coinciding therapeutic conditions.

Track 18: Intestinal Rehabilitation

Intestinal Rehabilitation deals with the process of restoring enteral autonomy and thus allowing freedom from parenteral nutrition usually by means of dietary, medical and occasionally surgical strategies. 

Intestinal rehabilitation occurs as a consequence of enhanced bowel adaptation or short bowel syndrome. A coordinated team of gastroenterologists, surgeons and nutritionists provide long-term care to Patients with short or malformed intestines.

Track 19: Treatment Advances in Digestive Diseases

Helicobacter pylori (H. pylori) infection is a typical infection which will raise the peptic ulcers disease and gastric cancer. Most people with H. pylori infection will not have any signs and symptoms. Diagnosis can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate.

Non-steroidal anti-inflammatory drugs (NSAIDs) are most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, haemorrhage, perforation and death.

Track 20: Recent Advances in Gastroenterology

Gastroenterology emerged from the backwoods of medical specialties only over the past 20 years. It is due to the  massive improvement in the field of diagnosis and treatment. Gastroenterology is further divided into hepatology and “hollow organ” gastroenterology. Colorectal cancer screening, capsule endoscopy can diagnosis   hepatitis C.

Neurogastroenterology is the study dealing with the brain, gut, and their interactions with relevance to the understanding and management of gastrointestinal motility and functional gastrointestinal disorders. Precisely, neurogastroenterology targets  the functions, malfunctions, and the malformations of the sympathetic, parasympathetic, and enteric divisions of the digestive tract.

Peroral endoscopic myotomy (POEM) is an advance effective therapeutic option for esophageal achalasia.

Track 21: Entrepreneur Investment Meet

Gastro Meet 2019 facilitates a unique platform for transforming potential ideas into great business. The meeting creates a global platform aimed to connect global Entrepreneurs, Proposers and the Investors in the field of Medicine, Technology and many more. Allied sciences are the one which will develop and facilitate the most optimized and viable business for engaging people in to constructive discussions, evaluation and execution of promising business.

Relevant Conferences: Gastroenterology Conferences | Digestive Disorders Meetings | Hepatology Conferences

• 17^th International Conferences on Gastroenterology and Hepatology, November 18-19, 2019 Abu Dhabi, UAE
• International Metabolic Diseases and Liver Cancer Conference, December 16-17, 2019 Dubai, UAE
• International Conference on Diabetes and Cholesterol Metabolism, November 25-26, 2019 Dubai, UAE
• 10^th International Conference on Liver Diseases & Hepatology, December 02-03, 2019, Tokyo, Japan
• 20^th World Congress on Gastroenterology, November 18-19, 2019 Rome, Italy
• Mayo Clinic Gastroenterology & Hepatology Board Review 2019, September 05-08, 2019, Chicago, United States
• German Society Of Gastroenterology, Digestive And Metabolic Diseases - Viszeralmedizin 2019, October 02-05, 2019, Wiesbaden , Germany
• Glasgow Gastro Conference 2019, October 04, 2019, Glasgow, United Kingdom
• 27^th United European Gastroenterology Week 2019, October 19-23, 2019, Barcelona, Spain
• American College Of Gastroenterology Annual Scientific Meeting And Postgraduate Course 2019, October 25-30, 2019, San Antonio, United States

Related Associations:

Middle East: Lebenese of Gastroenterology, Iraqi Society of Gastroenterology and Hepatology, Egyptian Network of Gastroenterology & Hepatology, Iranian Association of Gastroenterology and Hepatology, Islamabad Gastroenterology Associates

Asia Pacific: Endoscopy Section of the Netherlands Society of Gastroenterology, Asian Pacific Association for the Study of the Liver, Asian Pacific Association of Gastroenterology, Indian Association of Gastrointestinal Endoscopy, The Japanese Society of Gastroenterology, Japan Gastroenterological Endoscopy Society, Indonesian Society of Gastroenterology, Taiwan Surgical Society Of Gastroenterology, Philippine Society of Gastroenterology.

Europe: The European Society of Gastroenterology and Endoscopy Nurses and Associates, United European Gastroenterology, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, European Society of Gastrointestinal Endoscopy, The European Federation of Crohn's & Ulcerative Colitis Associations, Belgium society of Gastrointestinal Endoscopy.

USA: World  Gastroenterology Organisation, American Society for Gastrointestinal Endoscopy, American Gastroenterological Association, American Society of Bariatric Physicians, British Society of Gastroenterology, Society of American Gastrointestinal and Endoscopic Surgeons, American Society of Transplant Surgeons, The Phoenix Society of Gastroenterology, Western Gastroenterology, San Diego Gastroenterology Society, Florida Gastroenterologic Society, Georgia Gastroenterologic and Endoscopic Society, Delaware Valley (PA) Society for Gastroenterological Endoscopy, North Carolina Society of Gastroenterology, New York Society for Gastrointestinal Endoscopy, Texas Society for Gastroenterology and Endoscopy, Crohn's & Colitis Foundation of America, Canadian Association of Gastroenterology.

Scope and Importance

Gastroenterology

Gastroenterology deals not only with the gastrointestinal disorders or infections of the GI tract and accessory organs, but also with the gastrointestinal therapies, drugs, therapeutics, and devices that are used in the diagnosing of the infections and diseases of the GI tract. According to a recent survey, 6 in 10 people globally, suffer from some form of gastrointestinal disorder at any given point in time. Primarily, the causes of the prevalence of chronic digestive and related diseases are due to lifestyle changes, lack of exercise, overeating, depression, anxiety, and socio-economic and emotional factors.

Why it’s in Abu Dhabi, UAE ?

Gastro Meet 2019 is going to be held in Abu Dhabi. Abu Dhabi is the capital and most populous city of the United Arab Emirates (UAE). It is extremely well known for its warm hospitality, rich cultural heritage, ultramodern architecture, luxury shopping and the Emirati people are welcoming and lavish in their approach to visitors. The city Abu Dhabi has the world's largest hand-loomed carpet in Sheikh Zayed Mosque, the fastest roller coaster Formula Rossa, Capital gate-the tower with the greatest lean, the largest cluster of cultural buildings and so on. Yas Island is an artificial island in Abu Dhabi, UAE. Yas Island can be reached by plane, boat or even by car. Yas Island was named as the world's leading tourism project at the World Travel Awards in November 2009. Abu Dhabi has numerous dining options and visitors are often confused by the sheer volume and diversity of choice across the emirate.

Why to attend???

As many People in the world are focused on learning about the Digestive system and its disorders. This is your best opportunity to reach the largest assemblage of participants from the Gastroenterologists and Hepatologists Community. Conduct presentations, distribute information, meet with current and potential scientists and Doctors, make a splash with new therapeutics and surgical methods, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in and Digestive treatment are hallmarks of this conference.

Gastrointestinal disorders include such conditions as constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps, and cancer

Gastroenterologists perform a number of diagnostic and therapeutic procedures including colonoscopy, endoscopy, endoscopic retrograde cholangiancreatography (ERCP), endoscopic ultrasound and liver biopsy. Digestive Disorders is a complex medical issue that requires a multidisciplinary approach. This approach is sweeping and ranges from well-being advancement to counteractive action and screening, diagnosis, treatment, restoration, and Primitive Care.

Major Associations

• American Society for Gastrointestinal Endoscopy
• Indian Association of Gastrointestinal Endo Surgeons
• Society of Gastroenterology Nurses and Associates
•  The European Society of Gastroenterology and Endoscopy Nurses and Associates
• American Gastroenterological Association
• American Society of Bariatric Physicians 
• National Association for Colitis and Crohn's Disease 
• Crohn's & Colitis Foundation of America
• Society of American Gastrointestinal and Endoscopic Surgeons
• The Society of Gastroenterology Nurses and Associates
• British Society of Gastroenterology 
• The Bockus International Society of Gastroenterology.
• World Gastroenterology Organisation
• Ontario Association of Gastroenterology
• Canadian Association of Gastroenterology
• United European Gastroenterology
• Florida Gastroenterological Society
• Gastroenterological Society of Australia
• The Gastroenterological Society of Taiwan
• Indian Association of Surgical Gastroenterology

Major Universities associated with Gastroenterology in worldwide:

• IBS The University of Barcelona
• World Gastroenterology Organisation
• American College of Gastroenterology
• Medicine-Gastroenterology - University of Colorado
• Pediatrics - Gastroenterology - Stanford Medicine - Stanford University
• University of Pittsburgh
• Division of Gastroenterology & Hepatology – University of Virginia
• Gastroenterology and Hepatology: Department of Medicine: Feinberg
• Division of Gastroenterology - McMaster University
• Gastroenterology - Rush University Medical Center

Major Industries associated with Gastroenterology in worldwide:

• Covidien
• EndoChoice
• Frontier Healthcare
• Sun Pharmaceutical Industries Ltd.
• Alkem Laboratories
• Boston Scientific
• FUJIFILM Medical Systems
• Pentax Medical Company
• Olympus
• gMed
• Physicians Endoscopy
• US Endoscopy Group

Major Hospitals Associated with Gastroenterology in worldwide:

• Mayo Clinic
• Cleveland Clinic
• Johns Hopkins Hospital
• Massachusetts General Hospital
• Mount Sinai Hospital
• University of Chicago Medical Center
• Hospital of the University of Pennsylvania
• Ronald Reagan UCLA Medical Center
• New York-Presbyterian University Hospital of Columbia and Cornell
• Cedars-Sinai Medical Center
• UPMC-University of Pittsburgh Medical Center
• Barnes-Jewish Hospital/Washington University
• University of Michigan Hospitals and Health Centres
• Clarian Health
• Duke University Hospital
• University of Texas M.D. Anderson Cancer Center

Market Growth of Gastroenterology Research:

The global market for gastrointestinal disorder diagnostics and therapeutics reached $49.6 billion in 2015. This market is expected to grow nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

The prescription therapies  is expected to grow from $18.6 billion in 2016 to nearly $22.1 billion in 2021 at a CAGR of 3.5% for the period 2016-2021.

Based on the diagnostics market over the next five years will grow from $17.7 billion in 2016 to $23.5 billion in 2021 at a CAGR of 5.9% for the period 2016-2021.

The gastrointestinal pharmaceuticals market is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals. Similarly, the market for gastrointestinal diagnostics, testing, and a vaccine is divided into three general segments:  Diagnostics and testing market, Medical devices (endoscopy), Vaccines. It is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following:

• Gastrointestinal tract disorders.

• Gastrointestinal tract walls disorders.

• Gastrointestinal motility disorders.

• Gastrointestinal Cancers

Increase in the instances of Crohn’s disease, inflammatory bowel disease, ulcerative colitis, and such other diseases are also expected to create a rise in demand for the gastrointestinal diseases market. The growth in the demand and sale for the gastrointestinal drugs across the developing and developed markets is also attributed to be one of the major driving factors for this market. The growing investments and the research & development activities by the key market players are also expected to play a vital role in the overall growth of this market. The major restraining factors for the market include advancements in the new alternative therapies and the regulatory restraints.

The aim of the market research is to increase the awareness of gastrointestinal disorders among people and to identify the gastrointestinal market landscape as well as important advancements.

This analysis various therapeutic options currently on the market as well as potential products and classes of products that are likely to have a significant impact on the future for the prescription as well as the over-the-counter (OTC) gastrointestinal drug markets. The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters.

Fig- Global Gastrointestinal Drugs Market Revenue by Region, 2016

According to Market research the Global Gastrointestinal Drugs Revenue by Region in 2016, North America was the highest by getting the revenue of 17,288 US Dollar Million, while the Middle East and Africa Continent have the least generated revenue.

But, the Future scope is much brighter in Coming years in Middle East countries. 

Fig: Global Ambulatory Surgery Centers Market share (%) by, 2023

Demand for ambulatory surgery centre is high in the Asia Pacific and Europe owing to the government initiatives to overcome the shortage of medical facilities in remote areas of developing countries such as India and China.

The North America ambulatory surgery centre market is expected to witness significant growth rate in future due to enough outpatient surgery centres and government regulations governing the preference for outpatient surgery centres in order to expand the reach of medical facilities.